bioskin joins Eurofins Scientific
bioskin is pleased to announce that as of August 1, 2021, the company has become part of the Eurofins Scientific Group.
With more than 800 laboratories in over 50 countries, Eurofins is the global leader in food, environment, pharmaceutical and cosmetic testing.
By joining the Eurofins network, we strengthen our position as a leading provider of clinical dermatological trials for pharmaceuticals and medical devices.
With its network of over 26 state-of-the-art laboratories, including 16 clinical laboratories operating throughout Europe, North America, Asia-Pacific and Africa, Eurofins Cosmetics & Personal Care offers an unmatched range of services. These include regulatory and toxicology services, physicochemical analysis, microbiology, ecotoxicity and biodegradability, in vitro testing, consumer testing & sensory analysis, audit services & consulting, in addition to clinical trials for the pharmaceutical industry.
Supported by Eurofins Cosmetics & Personal Care and benefiting from a wider scope of services and greater geographic coverage, bioskin will continue to provide highest quality CRO services. All our valued clients can continue to rely on us as your partner in clinical trial management and conduct.
Yann Agustin, Managing Director Cosmetics & Personal Care Product Testing Europe, commented, “We are pleased to welcome on board bioskin’s team. This acquisition will expand our capabilities in Germany and will even further strengthen our expertise in the field of clinical study management in particular in dermatology drugs and medical devices, adding highly recognised scientists to our network.”
Dr. Walter Wigger-Alberti, CEO of bioskin, said, “We very much appreciate being a part of Eurofins, and we look forward to fruitful cooperation and the exchange of great expertise between us and the valuable worldwide testing institutes that are part of Eurofins.”